Ms Tiffany Harris-Brown
Senior Clinical Research Manager & Senior Clinical Research Manager
UQ Centre for Clinical Research
+61 7 334 66072
Publications
Journal Articles
Cumpston, Miranda S., Webb, Steven A., Middleton, Philippa, Sharplin, Greg, Green, Sally, for the Australian Clinical Trials Alliance Reference Group on Impact and Implementation of CTN Trials, Best, Karen, Bloomfield, Frank, Cass, Alan, Cohen, Paul, Crengle, Sue, Cullen, Louise, Gantner, Dashiell, Gaulke, Heide, Ghersi, Davina, Green, Sally, Glasziou, Paul, Harris-Brown, Tiffany, Jan, Stephen, Johnson, David, Keogh, Samantha, Levi, Chris, Middleton, Philippa, Peake, Sandra, Scheppokat, Angela, Scuffham, Paul, Sharplin, Greg, Shaw, Tim, Story, David ... Zoungas, Sophia (2021). Understanding implementability in clinical trials: a pragmatic review and concept map. Trials, 22 (1) 232. doi: 10.1186/s13063-021-05185-w
Wright, Hugh, Harris, Patrick N. A., Chatfield, Mark D., Lye, David, Henderson, Andrew, Harris-Brown, Tiffany, Donaldson, Anna and Paterson, David L. (2021). Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials, 22 (1) 889. doi: 10.1186/s13063-021-05870-w
Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387
McCarthy, K. L., Harris-Brown, T., Smits, E. J., Legg, A., Chatfield, M. D. and Paterson, D. L. (2021). The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial. European Journal of Clinical Microbiology & Infectious Diseases, 40 (12), 2505-2513. doi: 10.1007/s10096-021-04294-3
Henderson, A., Paterson, D. L., Chatfield, M. D., Tambyah, P. A., Lye, D. C., De, P. P., Lin, R. T. P., Chew, K. L., Yin, M., Lee, T. H., Yilmaz, M., Cakmak, R., Alenazi, T. H., Arabi, Y. M., Falcone, M., Bassetti, M., Righi, E., Rogers, B.A., Kanj, S. S., Bhally, H., Iredell, J., Mendelson, M., Boyles, T. H., Looke, D. F. M., Runnegar, N. J., Miyakis, S., Walls, G., AI Khamis, M., Zikri, A. ... For the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2020). Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study. Clinical Infectious Diseases, 73 (11), e3842-e3850. doi: 10.1093/cid/ciaa1479
Harris, Patrick N. A., Tambyah, Paul A., Lye, David C., Mo, Yin, Lee, Tau H., Yilmaz, Mesut, Alenazi, Thamer H., Arabi, Yaseen, Falcone, Marco, Bassetti, Matteo, Righi, Elda, Rogers, Benjamin A., Kanj, Souha, Bhally, Hasan, Iredell, Jon, Mendelson, Marc, Boyles, Tom H., Looke, David, Miyakis, Spiros, Walls, Genevieve, Al Khamis, Mohammed, Zikri, Ahmed, Crowe, Amy, Ingram, Paul, Daneman, Nick, Griffin, Paul, Athan, Eugene, Lorenc, Penelope, Baker, Peter ... MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2018). Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA, 320 (10), 984-994. doi: 10.1001/jama.2018.12163
Furuya-Kanamori, Luis, Riley, Thomas V., Paterson, David L., Foster, Niki F., Huber, Charlotte A., Hong, Stacey, Harris-Brown, Tiffany, Robson, Jenny and Clements, Archie C. A. (2017). Comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities. Journal of Clinical Microbiology, 55 (1), 216-225. doi: 10.1128/JCM.01779-16
Furuya-Kanamori, L., Clements, A. C. A., Foster, N. F., Huber, C. A., Hong, S., Harris-Brown, T., Yakob, L., Paterson, D. L. and Riley, T. V. (2017). Asymptomatic Clostridium difficile colonization in two Australian tertiary hospitals, 2012-2014: prospective, repeated cross-sectional study. Clinical Microbiology and Infection, 23 (1), 48.e1-48.e7. doi: 10.1016/j.cmi.2016.08.030
Trubiano, J. A., Worth, L. J., Urbancic, K., Brown, T. M., Paterson, D. L. and Lucas, M. (2016). Return to sender: the need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal, 46 (11), 1311-1317. doi: 10.1111/imj.13221
Zowawi, Hosam Mamoon, Abedalthagafi, Malak, Mar, Florie A., Almalki, Turki, Kutbi, Abdullah H., Harris-Brown, Tiffany, Harbarth, Stephan, Balkhy, Hanan H., Paterson, David L. and Hasanain, Rihab Abdalazez (2015). The potential role of social media platforms in community awareness of antibiotic use in the gulf cooperation council states: luxury or necessity?. Journal of Medical Internet Research, 17 (10) e233, e233. doi: 10.2196/jmir.3891
Harris, Patrick N. A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany and Paterson, David L. (2015). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 (1) 24, 24.1-24.8. doi: 10.1186/s13063-014-0541-9
Harris-Brown, Tiffany M. and Paterson, David L. (2015). Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference. Perspectives in Clinical Research, 6 (3), 139-143. doi: 10.4103/2229-3485.159937
Rogers, Benjamin A., Havers, Sally M., Harris-Brown, Tiffany M. and Paterson, David L. (2014). Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: Analysis of a national survey. American Journal of Infection Control, 42 (9), 963-969. doi: 10.1016/j.ajic.2014.05.035